Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TILthis companyInstil Bio, Inc.	$6.90	-1.03×	0.64×	0×	-2.34×	-279.7%	0.0%	0.0%	0.0%	-62.7%	-26.6%	-49.9%	0.75×	-1.21×	-9.08×	39.53×	0.0%	3	-4.99	2	B-
ATOSAtossa Therapeutics, Inc.	$2.13	-2.19×	1.94×	0×	-1×	88.9%	0.0%	0.0%	0.0%	-88.4%	-94.4%	-39.1%	0×	1.19×	0×	5.53×	0.0%	1	-11.86	2	B-
MGNXMacroGenics, Inc.	$2.47	-1.36×	1.83×	0.68×	-2.54×	-2714.5%	71.1%	-48.7%	-49.9%	-134.2%	-33.0%	-81.6%	1.92×	-0.83×	-8.56×	5.1×	0.0%	1	-4.43	1	D+
ONCYOncolytics Biotech Inc.	$0.45	-2.92×	-22.05×	0×	-3.79×	-94.9%	0.0%	0.0%	0.0%	551.7%	-1250.6%	-17.5%	-0.15×	0.22×	0×	1.12×	0.0%	1	-95.51	2	C
PLRXPliant Therapeutics, Inc.	$0.80	-0.5×	0.41×	0×	-0.4×	-67.7%	0.0%	0.0%	0.0%	-82.4%	-71.4%	-171.9%	0.16×	0.11×	-58.65×	12×	0.0%	2	-6.55	2	B-
SRZNSurrozen, Inc.	$32.56	-0.7×	-0.9×	48.61×	-0.36×	-60.9%	84.6%	-1210.6%	-6960.8%	128.9%	-46.7%	-18.0%	-0.04×	0.34×	0×	9.22×	0.0%	1	-15.27	2	C+
Peer median	—	-1.36×	0.41×	0×	-1×	-67.7%	0.0%	0.0%	0.0%	-82.4%	-71.4%	-39.1%	0×	0.22×	0×	5.53×	0.0%	1	-11.86	2	—